Evidence map›Paper›PMID 38856006›Full record

ArticleAmerican journal of industrial medicine2024

Distribution of COVID-19 mitigation measures by industry and work arrangement-US blood donors, May 2021-December 2021.

Dallas S Shi, Jessica L Rinsky, Emily McDonald, Melisa M Shah, Matthew R Groenewold, Marie A de Perio, Leora R Feldstein, Sharon Saydah, James M Haynes, Bryan R Spencer and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of industrial medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dallas S ShiDivision of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.ORCID 0000-0001-8088-6427
Jessica L RinskyDivision of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.
Emily McDonaldDivision of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.
Melisa M ShahDivision of Coronaviruses and Other Respiratory Viruses, National Center for Immunizations and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Matthew R GroenewoldDivision of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.ORCID 0000-0003-4662-7813
Marie A de PerioOffice of the Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.
Leora R FeldsteinDivision of Coronaviruses and Other Respiratory Viruses, National Center for Immunizations and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sharon SaydahDivision of Coronaviruses and Other Respiratory Viruses, National Center for Immunizations and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
James M HaynesAmerican Red Cross, Scientific Affairs, Dedham, MA, Rockville, Maryland, USA.
Bryan R SpencerAmerican Red Cross, Scientific Affairs, Dedham, MA, Rockville, Maryland, USA.
Susan L StramerAmerican Red Cross, Scientific Affairs, Dedham, MA, Rockville, Maryland, USA.
Matthew McCulloughDivision of Coronaviruses and Other Respiratory Viruses, National Center for Immunizations and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jefferson M JonesDivision of Coronaviruses and Other Respiratory Viruses, National Center for Immunizations and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sophia K ChiuDivision of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveTo describe coronavirus disease 2019 (COVID-19) mitigation measures in workplaces of employed US blood donors by industry and work arrangement.

methodsDuring May-December 2021, blood donors responded to a survey; we describe the distribution of reported workplace mitigation measures by industry and work arrangement, organized using the hierarchy of controls.

resultsOf 53,433 respondents representing 21 industries, ventilation upgrades were reported by 4%-38% of respondents (overall: 20%); telework access ranged from 14%-80% (53% overall). Requiring masks (overall: 84%; range: 40%-94%), physical distancing (77%; 51%-86%), paid leave for illness (70%; 38%-87%), and encouraging vaccination (61%; 33%-80%) were common. Independent workers reported fewer mitigation measures than those in traditional employment settings.

conclusionsMitigation measures varied by industry and work arrangement. Some mitigation measures may be challenging to implement or irrelevant in certain industries, supporting the idea that mitigation is not a one-size-fits-all strategy. POLICY IMPLICATIONS: Tailored strategies to mitigate workplace risks of disease transmission are vital. Strategies should rely on effective methods for identifying workplace controls (e.g., through the hierarchy of controls) and account for industry-specific characteristics and workplace environments.

Indexed as

Blood DonorsCOVID-19SARS-CoV-2WorkplaceAdultFemaleHumansIndustryMaleMasksMiddle AgedPhysical DistancingSurveys and QuestionnairesTeleworkingUnited StatesVaccinationblood donorsCOVID‐19industrymitigationSARS‐CoV‐2work

Identifiers

PMID38856006
PMCPMC11265519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.